FDA grants priority review to Alimera drug Iluvien BusinessWeek Alimera Sciences Inc. said Monday regulators granted priority review to its potential diabetic macular edema treatment, Iluvien. ... Alimera Sciences' Iluvien(R) Receives FDA Priority Review for the Treatment of ... Alimera Sciences eye therapy gets FDA priority review Pluristem up on heart study. After the bell Alimera gets FDA priority review |
Monday, August 30, 2010
FDA grants priority review to Alimera drug Iluvien - BusinessWeek
http://www.kasabati.com/article/REMAX-Founders-Sanctuary-Ranked-Top-100-Golf-Course-By-Golf-Digest.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment